Ophthalmic Drugs Market – (Prescription Type – Prescription Ophthalmic Drugs and Over the Counter (OTC) Drugs; Therapeutic Type: Glaucoma Ophthalmic Drugs, Retinal Disorder Ophthalmic Drugs, Dry Eye Ophthalmic Drugs and Allergic Conjunctivitis): Market Growth, Future Prospects and Competitive Analysis, 2017-2023, the market was valued at USD 19.6 Bn in 2017, and is expected to reach USD 46.9 Bn by 2025, expanding at a CAGR of 7.0% from 2017 to 2025.
Browse Full Report Click Here: http://www.acutemarketreports.com/report/ophthalmic-drugs-market-report
Market Insights
Globally, average life expectancy has been increasing and it’s posturing medical issues within the ophthalmology field. Among the elderly population, vision loss is a major healthcare problem. The growing prevalence of eye–related disorders has created huge scope for ophthalmic drugs. Moreover, new technologies combining drugs and device therapies are contributing significantly towards the development of ophthalmic drugs market. North America accounted for the largest market in the ophthalmic drugs market due to the rising number of patient population suffering from ocular diseases in the region.
The prevalence of blindness and vision impairment and other eye related disorders is expected to increase rapidly among all age group, gender and racial group in North America. Asia Pacific ophthalmic drug market holds high growth potential in near future due to factors such as rising geriatric population, rising investments in healthcare infrastructure and increasing prevalence of ocular diseases.
Browse The Complete Report At http://www.acutemarketreports.com/report/ophthalmic-drugs-market-report
The ophthalmic drug industry can be classified into prescription ophthalmic drugs and over the counter (OTC) drugs. OTC drugs held the largest market share in the global ophthalmic drugs market.
However, prescription ophthalmic drugs segment is anticipated to grow at highest CAGR during the forecast period due to the increasing rate of success for newly launched drugs which can only be bought by prescriptions assisting the market growth. Among the therapeutic areas, glaucoma ophthalmic drugs held the largest share in global ophthalmic drugs market. It is estimated that over three million Americans are suffering from glaucoma, being the leading cause of blindness in people of 60 years of age.
However, the retinal disorder ophthalmic drug is anticipated to grow at highest CAGR due higher prevalence rate among people in the world. Thus the treatment for retinal disorders has the highest growth.
Browse All Reports of This Category: http://www.acutemarketreports.com/category/ophthalmic-devices-market
Table of Content :
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.2 List and Data Sources
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.2 List and Data Sources
Chapter 2 Executive Summary
2.1 Global Ophthalmic Drugs Market - Industry Summary & Key Buying Criteria
2.2 Global Ophthalmic Drugs Market - Industry Outlook
2.1 Global Ophthalmic Drugs Market - Industry Summary & Key Buying Criteria
2.2 Global Ophthalmic Drugs Market - Industry Outlook
Chapter 3 Market Segmentation
3.1 Market Size and Growth Prospects 2015 - 2025
3.2 Global hthalmic Drugs Industry Value Chain Analysis
3.3 Vendor Landscape
3.1 Market Size and Growth Prospects 2015 - 2025
3.2 Global hthalmic Drugs Industry Value Chain Analysis
3.3 Vendor Landscape
Chapter 4 Global Ophthalmic Drugs Market Dynamics
4.1 Market Driver Analysis
4.1.1 Global Rise in Geriatric Population Pushing Ophthalmology Drugs
4.1.2 Technology Advancement
4.1.3 Innovation Giving Rise To Ophthalmology Drugs Market
4.1.4 Global Increase In Prevelance of Eye Diseases
4.1.5 Global Increase in Healthcare Expenditure
4.2 Market Driver Analysis
4.2.1 Major Drugs Going Off Patent Is Affecting the Growth of Ophthalmology Market
4.2.2 Drying Pipelines Is A Concern For Major Players
4.3 Key Opportunities Prioritized
4.2.1 Increasing Awareness
4.2.2 Emerging Markets
4.1 Market Driver Analysis
4.1.1 Global Rise in Geriatric Population Pushing Ophthalmology Drugs
4.1.2 Technology Advancement
4.1.3 Innovation Giving Rise To Ophthalmology Drugs Market
4.1.4 Global Increase In Prevelance of Eye Diseases
4.1.5 Global Increase in Healthcare Expenditure
4.2 Market Driver Analysis
4.2.1 Major Drugs Going Off Patent Is Affecting the Growth of Ophthalmology Market
4.2.2 Drying Pipelines Is A Concern For Major Players
4.3 Key Opportunities Prioritized
4.2.1 Increasing Awareness
4.2.2 Emerging Markets
Chapter 5 Industry Analysis
6.1 Global Ophthalmic Drugs Market Industry - PESTEL Analysis
6.1 Global Ophthalmic Drugs Market Industry - PESTEL Analysis
Chapter 6 Global Ophthalmic Drugs Market, By Prescription Type, 2015 - 2025 (USD Mn)
6.1 Global Prescription Market For Ophthalmic Drugs, 2015 - 2025 (USD Mn)
6.2 Global OTC (Over The Counter ) Drugs Ophthalmic Drugs Market 2015 - 2025 (USD Mn)
6.1 Global Prescription Market For Ophthalmic Drugs, 2015 - 2025 (USD Mn)
6.2 Global OTC (Over The Counter ) Drugs Ophthalmic Drugs Market 2015 - 2025 (USD Mn)
Latest Reports:
About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us:
Name : Chris Paul
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
No comments:
Post a Comment